Skip to main content

Endothelial cell autoantibodies in predicting declining renal function, end-stage renal disease, or death in adult type 2 diabetic nephropathy

Publication ,  Journal Article
Zimering, MB; Zhang, JH; Guarino, PD; Emanuele, N; McCullough, PA; Fried, LF; Servilla, K; Seliger, S; Purohit, N; Kaufman, J; Lohr, J; Ma, K ...
Published in: Frontiers in Endocrinology
January 1, 2014

Albuminuria is a strong predictor of diabetic nephropathy chronic kidney disease outcomes. Yet, therapeutic albuminuria-lowering has not consistently translated into a reduction in clinical events suggesting the involvement of additional pathogenic factors. Our hypothesis is that anti-endothelial cell autoantibodies play a role in development and progression in diabetic nephropathy. We determined anti-endothelial cell antibody (AECA) bioactivity in protein A-elutes of baseline plasma in 305 participants in the VA NEPHRON-D study, a randomized trial of angiotensin receptor blocker (ARB) or dual ARB plus angiotensin-converting enzyme inhibitor therapy in type 2 diabetes with proteinuric nephropathy. Thirty-eight percent (117/305) of participants had significantly reduced endothelial cell survival (≤80%) in the IgG fraction of plasma. A VA NEPHRON-D primary endpoint [end-stage renal disease (ESRD), significant reduction in estimated glomerular filtration rate, or death] was experienced by 58 individuals. In adjusted Cox regression analysis, there was a significant interaction effect of baseline anti-endothelial cell-mediated cell survival and albuminuria on the hazard rate (HR) for primary composite endpoint (P = 0.017). Participants lacking strongly inhibitory antibodies with albuminuria ≥1 g/g creatinine had a significantly increased primary event hazard ratio, 3.41 - 95% confidence intervals (CI 1.84-6.33; P < 0.001) compared to those lacking strongly inhibitory antibodies with lower baseline albuminuria (<1 g/g creatinine). These results suggest that anti-endothelial cell antibodies interact significantly with albuminuria in predicting the composite endpoint of death, ESRD, or substantial decline in renal function in older, adult type 2 diabetic nephropathy.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Frontiers in Endocrinology

DOI

EISSN

1664-2392

Publication Date

January 1, 2014

Volume

5

Issue

AUG

Related Subject Headings

  • 3202 Clinical sciences
  • 1111 Nutrition and Dietetics
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Zimering, M. B., Zhang, J. H., Guarino, P. D., Emanuele, N., McCullough, P. A., Fried, L. F., … Crowley, S. (2014). Endothelial cell autoantibodies in predicting declining renal function, end-stage renal disease, or death in adult type 2 diabetic nephropathy. Frontiers in Endocrinology, 5(AUG). https://doi.org/10.3389/fendo.2014.00128
Zimering, M. B., J. H. Zhang, P. D. Guarino, N. Emanuele, P. A. McCullough, L. F. Fried, K. Servilla, et al. “Endothelial cell autoantibodies in predicting declining renal function, end-stage renal disease, or death in adult type 2 diabetic nephropathy.” Frontiers in Endocrinology 5, no. AUG (January 1, 2014). https://doi.org/10.3389/fendo.2014.00128.
Zimering MB, Zhang JH, Guarino PD, Emanuele N, McCullough PA, Fried LF, et al. Endothelial cell autoantibodies in predicting declining renal function, end-stage renal disease, or death in adult type 2 diabetic nephropathy. Frontiers in Endocrinology. 2014 Jan 1;5(AUG).
Zimering, M. B., et al. “Endothelial cell autoantibodies in predicting declining renal function, end-stage renal disease, or death in adult type 2 diabetic nephropathy.” Frontiers in Endocrinology, vol. 5, no. AUG, Jan. 2014. Scopus, doi:10.3389/fendo.2014.00128.
Zimering MB, Zhang JH, Guarino PD, Emanuele N, McCullough PA, Fried LF, Servilla K, Seliger S, Purohit N, Kaufman J, Lohr J, Lopes-Virella M, Miller R, Othersen J, Reilly R, Kourany W, Quinn S, Leehey D, Lteif A, Dixon B, Goel A, Krause M, McMillan J, Wall B, Ma K, Ikizler A, Blumenthal S, Anderson R, Lit Y, Baker P, Ramkumar M, Watnick S, Zieve F, Gopalakrishnan R, Benabe J, Lamarche J, Crowley S. Endothelial cell autoantibodies in predicting declining renal function, end-stage renal disease, or death in adult type 2 diabetic nephropathy. Frontiers in Endocrinology. 2014 Jan 1;5(AUG).

Published In

Frontiers in Endocrinology

DOI

EISSN

1664-2392

Publication Date

January 1, 2014

Volume

5

Issue

AUG

Related Subject Headings

  • 3202 Clinical sciences
  • 1111 Nutrition and Dietetics
  • 1103 Clinical Sciences